[Use of miocamycin in the acute exacerbation of chronic obstructive bronchopneumopathy. Case material contribution].
18 patients with chronic obstructive bronchitis were treated with 900 mg myomycin a day. The clinical parameters examined were the quantity and organoleptic characteristics of the expectoration, coughing, and body temperature. These parameters were studied immediately before and 7.14 and 21 days after the start of treatment. Myomycin was found to be satisfactorily effective with minimal toxicity and well tolerated.
D000368:Aged; D003371:Cough / Q000188:drug therapy; D005260:Female; D005334:Fever / Q000188:drug therapy; D006801:Humans; D007933:Leucomycins / Q000627:therapeutic use*; D008173:Lung Diseases, Obstructive / Q000150:complications / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D015644:Miocamycin
D007933:Leucomycins; D015644:Miocamycin
L'impiego della miocamicina nelle riacutizzazioni della broncopneumopatia cronica ostruttiva. Contributo casistico.